SEC Comment Letter for COMPUGEN LTD (CGEN) (CIK 0001119774) (CGEN) — Aug 24, 2023
COMPUGEN LTD (CGEN) (CIK 0001119774)
Date: Aug. 24, 2023 · CIK: 0001119774 · Accession: 0000000000-23-009353
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-30902
Letter
United States securities and exchange commission logo August 24, 2023 Anat Cohen-Dayag President and Chief Executive Officer Compugen Ltd Azrieli Center 26 Harokmim Street Building D Holon 5885849 Israel Re:Compugen Ltd Form 20-F for Fiscal Year Ended December 31, 2022 Filed February 28, 2023 File No. 000-30902 Dear Anat Cohen-Dayag: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
August 24, 2023
Anat Cohen-Dayag
President and Chief Executive Officer
Compugen Ltd
Azrieli Center
26 Harokmim Street
Building D
Holon 5885849 Israel
Re:Compugen Ltd
Form 20-F for Fiscal Year Ended December 31, 2022
Filed February 28, 2023
File No. 000-30902
Dear Anat Cohen-Dayag:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences